SEC Form 4 · accession 0001209191-18-062404
AETHLON MEDICAL INC · AEMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy C Rodell Jr.
Officer — Interim CEO
Period of report
Dec 10, 2018
Accepted (ET)
Dec 13, 2018 · 1:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882291
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $1.25 | Dec 10, 2018 | A | 552,625 | A | — | Dec 9, 2028 | Common Stock | 552,625 | 552,625 | D |
Explanation of responses
- F125% of the shares subject to the stock option shall vest and become exercisable on December 10, 2019, and the remaining shares shall vest and become exercisable in 36 equal monthly installments thereafter.